Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy - Wikidata - wikimedia - TriplyDB

Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy

Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy

http://www.wikidata.org/entity/Q33727749

about

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed Serum and tissue leptin in lung cancer: A meta-analysis.The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.

P2860

Q36070007-C18CB35D-4A5E-4DB4-9452-CF494F86F747 Q37746107-6FF14ED4-EA87-4FFC-8E04-5116F169A51D Q55432585-A6EA70F1-49E6-48EC-8A00-81509D4941E9

P2860

Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy

http://www.wikidata.org/entity/Q33727749

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@ast

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@en

type

label

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@ast

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@en

prefLabel

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@ast

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@en

P1433

Q33727749-176714EC-E932-432C-A4F7-8A02045E8436

P1476

Q33727749-297D2281-3387-4F9E-9B26-294EF4911D9B

P2093

Q33727749-00C811B1-C448-446B-B0D8-5B9FFA7FD79E

Q33727749-07FAE053-248C-4ACA-853B-CEDF664C2FC6

Q33727749-59AF9E8B-E3D1-4A43-AEFD-A0D598FC23F0

Q33727749-6956F519-FAB2-47F0-85BB-5CFA4C8B8CB3

Q33727749-723B9C1A-DB7B-425A-864C-75C055E19487

Q33727749-8BA6840F-5F76-4886-A91B-CA12AA7317DC

Q33727749-B2DFE762-0A19-42E2-A3CD-5C7F1E3BB5B9

Q33727749-B8CAACE8-97B1-4FA7-A7A3-2FB89F177DFF

Q33727749-C014EA7C-4735-4497-8737-EAE85AB3FB20

Q33727749-D0B723DD-6D5C-4F38-9546-D091D62F28A7

P2860

Q33727749-04A4BDB7-5147-4862-B295-88E809FB06D9

Q33727749-073ED517-96D0-4577-9934-1708069B44E4

Q33727749-0F7C0DD6-7647-4DC4-8770-4DCD50698550

Q33727749-344539FD-FF83-43B4-A319-B9E4F9C40EF0

Q33727749-41093545-CEED-429D-A423-7C6BE5F86A05

Q33727749-43152072-0019-4072-A229-39C5DCCFDC96

Q33727749-464D96BC-D4D3-4C7A-9FAD-34CEDD69A9E4

Q33727749-574E60D9-67FF-4056-841B-052CF56C28A7

Q33727749-68B10BE9-82ED-4067-BB96-0E1810D6F940

Q33727749-773F22C3-1F59-4836-8436-A656F8286138

P304

Q33727749-6A80605F-764B-4F5C-8F30-4698527D4761

P31

Q33727749-5A01509F-0A17-46F7-A1EA-7AC8430E5744

P356

Q33727749-1734501D-69B2-4871-ABE5-DD1CF12D14BF

P433

Q33727749-6CE57AF7-77DB-49A5-B1A7-BF200289C977

P478

Q33727749-B28AA68B-96FE-437B-AA72-1F95058C818C

P577

Q33727749-FA708E84-3192-4EB6-8E5B-089522939BC0

P5875

Q33727749-BD512AE5-6CAA-4B58-89E6-A2E237C1E5E5

P698

Q33727749-2164AFE2-5D34-4CB2-A3EA-8B62C7A2FECA

P921

Q33727749-65CC287C-F2E6-481A-A95B-8F05494943B4

Q33727749-E7A0D6CA-BCC2-4710-AE84-C66F5DBFEBEF

P932

Q33727749-E8BCC484-2BA5-427C-98A8-89FFF904A74B

P356

P1433

Oncology Letters

P1476

Prognostic value of serum lept ...... platin/pemetrexed chemotherapy

@en

P2093

Chunyan Zhang

http://www.w3.org/2001/XMLSchema#string

Guangtao Yan

http://www.w3.org/2001/XMLSchema#string

Hongli Tong

http://www.w3.org/2001/XMLSchema#string

Hui Xue

http://www.w3.org/2001/XMLSchema#string

Jing Dong

http://www.w3.org/2001/XMLSchema#string

Qiyu Sun

http://www.w3.org/2001/XMLSchema#string

Shengjie Sun

http://www.w3.org/2001/XMLSchema#string

Wenjun Mou

http://www.w3.org/2001/XMLSchema#string

Xinyu Wen

http://www.w3.org/2001/XMLSchema#string

Yaping Tian

http://www.w3.org/2001/XMLSchema#string

P2860

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.

Endogenous leptin fluctuates in hepatic ischemia/reperfusion injury and represents a potential therapeutic target.

Cancer burden in the year 2000. The global picture.

Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.

Potential role of leptin expression in hepatocellular carcinoma.

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.

CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.

Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?

ERCC1 and RRM1: ready for prime time?

Molecular profiling in non-small cell lung cancer: a step toward personalized medicine.

P304

2073-2078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.1988

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263131966

http://www.w3.org/2001/XMLSchema#string

P698

24932291

http://www.w3.org/2001/XMLSchema#string

P921

P932

4049753

http://www.w3.org/2001/XMLSchema#string